BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17658469)

  • 21. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
    Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
    Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
    Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
    Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.
    Puca R; Nardinocchi L; Starace G; Rechavi G; Sacchi A; Givol D; D'Orazi G
    Free Radic Biol Med; 2010 May; 48(10):1338-46. PubMed ID: 20171273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
    Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
    Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
    Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis and functions of p53R2 in zebrafish.
    Shang H; Li Q; Feng G; Cui Z
    Gene; 2011 Apr; 475(1):30-8. PubMed ID: 21194559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
    Dregoesc D; Rybak AP; Rainbow AJ
    DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.
    Guittet O; Tebbi A; Cottet MH; Vésin F; Lepoivre M
    Nitric Oxide; 2008 Sep; 19(2):84-94. PubMed ID: 18474260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
    Gresko E; Möller A; Roscic A; Schmitz ML
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
    Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
    Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between Mdm2 and HIPK2 in the DNA damage response.
    Zhang XP; Liu F; Wang W
    J R Soc Interface; 2014 Jul; 11(96):. PubMed ID: 24829283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.
    Hofmann TG; Glas C; Bitomsky N
    Bioessays; 2013 Jan; 35(1):55-64. PubMed ID: 23169233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
    Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
    Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
    FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
    Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
    Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
    Albrechtsen N; Dornreiter I; Grosse F; Kim E; Wiesmüller L; Deppert W
    Oncogene; 1999 Dec; 18(53):7706-17. PubMed ID: 10618711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
    Mannefeld M; Klassen E; Gaubatz S
    Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.